Meringa, Angelo
10  results:
Search for persons X
?
1

Combining CRISPR-Cas9 and TCR exchange to generate a safe a..:

Lo Presti, Vania ; Meringa, Angelo ; Dunnebach, Ester...
Journal for ImmunoTherapy of Cancer.  12 (2024)  4 - p. e008174 , 2024
 
?
6

Uncovering the mode of action of engineered T cells in pati..:

Dekkers, Johanna F ; Alieva, Maria ; Cleven, Astrid...
Dekkers , J F , Alieva , M , Cleven , A , Keramati , F , Wezenaar , A K L , van Vliet , E J , Puschhof , J , Brazda , P , Johanna , I , Meringa , A D , Rebel , H G , Buchholz , M-B , Barrera Román , M , Zeeman , A L , de Blank , S , Fasci , D , Geurts , M H , Cornel , A M , Driehuis , E , Millen , R , Straetemans , T , Nicolasen , M J T , Aarts-Riemens , T , Ariese , H C R , Johnson , H R , van Ineveld , R L , Karaiskaki , F , Kopper , O , Bar-Ephraim , Y E , Kretzschmar , K , Eggermont , A M M , Nierkens , S , Wehrens , E J , Stunnenberg , H G , Clevers , H , Kuball , J , Sebestyen , Z & Rios , A C 2023 , ' Uncovering the mode of action of engineered T cells in patient cancer organoids ' , Nature Biotechnology , vol. 41 , no. 1 , pp. 60-69 . https://doi.org/10.1038/s41587-022-01397-w.  , 2023
 
?
7

Uncovering the mode of action of engineered T cells in pati..:

Dekkers, Johanna F ; Alieva, Maria ; Cleven, Astrid...
Dekkers , J F , Alieva , M , Cleven , A , Keramati , F , Wezenaar , A K L , van Vliet , E J , Puschhof , J , Brazda , P , Johanna , I , Meringa , A D , Rebel , H G , Buchholz , M-B , Barrera Román , M , Zeeman , A L , de Blank , S , Fasci , D , Geurts , M H , Cornel , A M , Driehuis , E , Millen , R , Straetemans , T , Nicolasen , M J T , Aarts-Riemens , T , Ariese , H C R , Johnson , H R , van Ineveld , R L , Karaiskaki , F , Kopper , O , Bar-Ephraim , Y E , Kretzschmar , K , Eggermont , A M M , Nierkens , S , Wehrens , E J , Stunnenberg , H G , Clevers , H , Kuball , J , Sebestyen , Z & Rios , A C 2022 , ' Uncovering the mode of action of engineered T cells in patient cancer organoids ' , Nature Biotechnology . https://doi.org/10.1038/s41587-022-01397-w.  , 2022
 
1-10